The NYU Cancer Institute mourns the death of Jeremy Hill, who was a member of the NYUCI Advisory Board since 2010. He died in March at age 43 after a courageous fight against melanoma.
Mr. Hill was a Managing Director and Co-Head of Global Equity Finance at J.P.Morgan, a unit within the firm’s Prime Brokerage business. Prior to this role, he was a Senior Managing Director and Global Head of Equity Finance at Bear Stearns. A native of New Zealand, Mr. Hill held a BCom from the University of Auckland and an MBA from the University of Chicago.
He also served on the Board of Directors of the SAMFund, a nonprofit group in Boston which provides assistance to young adult survivors of can- cer to help the transition to life after treatment.
Lori Fink, Chair of the NYUCI Advisory Board, explained that when she met Mr. Hill in 2010, he believed the worst part of his cancer experience was behind him. “He felt he had his life ahead of him, this had been taken care of, and he wanted to be an upstanding citizen and make a difference,” Mrs. Fink noted.
William L. Carroll, MD, NYUCI Director, added, “Jeremy was a dedicated partner in shaping our Board and a generous, unflagging supporter of our work. We extend our deepest sympathies to his family.”